A comparative review of the isotretinoin pregnancy risk management programs across four continents

@article{Kovitwanichkanont2018ACR,
  title={A comparative review of the isotretinoin pregnancy risk management programs across four continents},
  author={T. Kovitwanichkanont and T. Driscoll},
  journal={International Journal of Dermatology},
  year={2018},
  volume={57}
}
Isotretinoin has revolutionized the treatment of severe acne vulgaris, a condition which if left untreated may result in significant socio‐psychological implications for those affected. Timely access to isotretinoin therapy is important to avoid the risks of potential physical and emotional scarring. However, due to its high risks of teratogenicity, isotretinoin must be used with care in females of childbearing potential. Since isotretinoin's introduction, numerous risk management programs have… Expand
9 Citations
Non-compliance with pregnancy prevention recommendations for isotretinoin in Korea between 2019–2020
  • Eun Jeong Choi, Jung Yeol Han
  • Medicine
  • Obstetrics & gynecology science
  • 2021
  • PDF
Isotretinoin: Still the cause of anxiety for teratogenicity
  • 2
An update on maternal medication-related embryopathies.
  • 1
Isotretinoin and Risk of Cardiovascular Events in Adults with Acne: A Population-based Retrospective Cohort Study

References

SHOWING 1-10 OF 48 REFERENCES
Does the teratogenicity of isotretinoin outweigh its benefits?
  • 6
Women's experiences with isotretinoin risk reduction counseling.
  • 12
  • PDF
The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system.
  • 80
SURVEY OF AUSTRALIAN ISOTRETINOIN PRESCRIBING
  • 3
Terminations of Pregnancy for Exposure to Oral Retinoids in South Australia, 1985–1993
  • 16
Epidemiology of isotretinoin exposure during pregnancy.
  • 96
...
1
2
3
4
5
...